Metatag Title
World Top Healthcare Companies in 2026
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2026, World Top Healthcare Companies by Market Cap in 2026.
World Top 100 Healthcare Companies List by Market Cap as of August 2026, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as of August 2026.
EBOS Group is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading marketer and distributor of recognized consumer products and animal care brands.
EBOS Group has over 3,700 employees and 61 locations across Australia and New Zealand.
ORPEA SA is a healthcare services providing company The headquarters is in France.
NuVasive is a Healthcare company. It is estimated 10 million U.S. adults suffer from chronic back pain each year which creates the third highest spend in U.S. healthcare. The company support includes online learning ,live clinical observation, case support and peer education. The headquarters is in USA.
In 2019, they achieved 1.168 billion USD in full-year revenue and it has 2,800 employees.
Piramal Group is a global business conglomerate with diverse interests in Pharma, Financial Services, Information Management, Real Estate and Glass Packaging. The Group has offices in over 30 countries and a global brand presence in more than 100 markets. Headquarters is in Mumbai of India.
Curaleaf Holdings is a Cannabis company. Curaleaf has a presence in 23 states, owns and operates 101 dispensaries, 23 cultivation sites, and 30 processing sites with a focus on highly populated, limited license states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. The headquarters is in USA.
Portola Pharmaceuticals is a Biotechnology company. It is having more than 380 employees and has offices around the globe and serves patients in more than 50 countries. The company has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome (aHUS) as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder.
Synlab AG is a healthcare systems and a leading provider of laboratory diagnostic services company in Europe for practicing doctors, clinics and patients. The headquarters is in Germany.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that is developing the investigational therapy Haduvio™ to treat serious chronic cough conditions by targeting the central and peripheral nervous systems. Headquarters is in USA.